Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2010 1
2011 2
2012 4
2013 5
2014 5
2015 11
2016 12
2017 10
2018 8
2019 8
2020 15
2021 29
2022 30
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth.
Niu M, Xu J, Liu Y, Li Y, He T, Ding L, He Y, Yi Y, Li F, Guo R, Gao Y, Li R, Li L, Fu M, Hu Q, Luo Y, Zhang C, Qin K, Yi J, Yu S, Yang J, Chen H, Wang L, Li Z, Dong B, Qi S, Ouyang L, Zhang Y, Cao Y, Xiao ZJ. Niu M, et al. Among authors: ouyang l. Nat Commun. 2021 Oct 11;12(1):5919. doi: 10.1038/s41467-021-26222-x. Nat Commun. 2021. PMID: 34635651 Free PMC article.
Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism.
Zhao L, Qiu Z, Yang Z, Xu L, Pearce TM, Wu Q, Yang K, Li F, Saulnier O, Fei F, Yu H, Gimple RC, Varadharajan V, Liu J, Hendrikse LD, Fong V, Wang W, Zhang J, Lv D, Lee D, Lehrich BM, Jin C, Ouyang L, Dixit D, Wu H, Wang X, Sloan AE, Wang X, Huan T, Mark Brown J, Goldman SA, Taylor MD, Zhou S, Rich JN. Zhao L, et al. Among authors: ouyang l. Nat Cancer. 2024 Jan;5(1):147-166. doi: 10.1038/s43018-023-00658-0. Epub 2024 Jan 3. Nat Cancer. 2024. PMID: 38172338
Proteolysis-targeting chimeras in breast cancer therapy.
Zhang J, Ouyang L. Zhang J, et al. Among authors: ouyang l. Future Med Chem. 2020 Dec;12(24):2175-2177. doi: 10.4155/fmc-2020-0279. Epub 2020 Nov 23. Future Med Chem. 2020. PMID: 33225735 Review. No abstract available.
Targeting epigenetic modifications in Parkinson's disease therapy.
Zhang D, Zhang J, Wang Y, Wang G, Tang P, Liu Y, Zhang Y, Ouyang L. Zhang D, et al. Among authors: ouyang l. Med Res Rev. 2023 Sep;43(5):1748-1777. doi: 10.1002/med.21962. Epub 2023 Apr 29. Med Res Rev. 2023. PMID: 37119043 Review.
Editorial: Novel biomarkers for anticancer therapy.
Wang T, Chen ZS, Shi C, Ouyang L, Xiao H. Wang T, et al. Among authors: ouyang l. Front Pharmacol. 2023 Jan 6;13:1109761. doi: 10.3389/fphar.2022.1109761. eCollection 2022. Front Pharmacol. 2023. PMID: 36686681 Free PMC article. No abstract available.
Medicinal chemistry strategies targeting PRMT5 for cancer therapy.
Fu S, Zheng Q, Zhang D, Lin C, Ouyang L, Zhang J, Chen L. Fu S, et al. Among authors: ouyang l. Eur J Med Chem. 2022 Dec 15;244:114842. doi: 10.1016/j.ejmech.2022.114842. Epub 2022 Oct 14. Eur J Med Chem. 2022. PMID: 36274274 Review.
145 results